Literature DB >> 11181042

FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells.

Y Sonoda1, D Yamamoto, S Sakurai, M Hasegawa, E Aizu-Yokota, T Momoi, T Kasahara.   

Abstract

FTY720, a metabolite from Isaria sinclairii, has been developed to be a potent immunosuppressive drug with induction of apoptosis in T cells and several cell lines. We investigated whether FTY720 induces apoptosis in human glioma cell lines, since they are relatively resistant to multiple apoptotic stimuli. In human glioma cells including T98G, FTY720 induced apoptosiswith ED50 between 1 to 10 microg/ml, while etoposidedid not induce apoptosis at the same doses. Among the caspase family proteases, mainly caspase-6 was activated during the apoptosis by FTY720 but not etoposide. In addition, FTY720 caused tyrosine dephosphorylation of FAK and did not activate a FAK-PI3-kinase survival pathway. This was confirmed also by the observation that orthovanadate prevented FTY720-induced dephosphorylation of FAK and inhibited FTY720-induced cell death. We assumed that FTY720 induced FAK dephosphorylation and cut off the FAK-PI3-kinase pathway resulting in the induction of apoptosis via caspase-6 activation in these glioma cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181042     DOI: 10.1006/bbrc.2001.4352

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.

Authors:  Takashi Yoshino; Hiroko Tabunoki; Shigeo Sugiyama; Keitaro Ishii; Seung U Kim; Jun-Ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.046

2.  The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.

Authors:  Karl Quint; Norbert Stiel; Daniel Neureiter; Hans Ulrich Schlicker; Christopher Nimsky; Matthias Ocker; Herwig Strik; Malgorzata Anna Kolodziej
Journal:  Tumour Biol       Date:  2014-06-06

3.  T cell selective apoptosis by a novel immunosuppressant, FTY720, is closely regulated with Bcl-2.

Authors:  Yukitoshi Nagahara; Masahiko Ikekita; Takahisa Shinomiya
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.

Authors:  Adriana Estrada-Bernal; Kamalakannan Palanichamy; Abhik Ray Chaudhury; James R Van Brocklyn
Journal:  Neuro Oncol       Date:  2012-02-20       Impact factor: 12.300

5.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.

Authors:  Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Anna M Eiring; Mario Notari; Bradley W Blaser; Shujun Liu; Rossana Trotta; Natarajan Muthusamy; Carlo Gambacorti-Passerini; Brian J Druker; Jorge Cortes; Guido Marcucci; Ching-Shih Chen; Nicole M Verrills; Denis C Roy; Michael A Caligiuri; Clara D Bloomfield; John C Byrd; Danilo Perrotti
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury.

Authors:  Mark D Okusa; Kevin R Lynch
Journal:  Drug Discov Today Dis Mech       Date:  2007

7.  Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.

Authors:  Justin Sharim; Randy Tashjian; Nima Golzy; Nader Pouratian
Journal:  J Clin Neurosci       Date:  2016-03-09       Impact factor: 1.961

8.  Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.

Authors:  Laura V Bownes; Raoud Marayati; Colin H Quinn; Andee M Beierle; Sara C Hutchins; Janet R Julson; Michael H Erwin; Jerry E Stewart; Elizabeth Mroczek-Musulman; Michael Ohlmeyer; Jamie M Aye; Karina J Yoon; Elizabeth A Beierle
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.639

Review 9.  Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance.

Authors:  Paola Giussani; Cristina Tringali; Laura Riboni; Paola Viani; Bruno Venerando
Journal:  Int J Mol Sci       Date:  2014-03-12       Impact factor: 5.923

Review 10.  Fingolimod for the treatment of neurological diseases-state of play and future perspectives.

Authors:  Robert Brunkhorst; Rajkumar Vutukuri; Waltraud Pfeilschifter
Journal:  Front Cell Neurosci       Date:  2014-09-12       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.